Achilles Therapeutics (ACHL)
1.16
0.00 (0.00%)
At close: Jan 14, 2025, 3:59 PM
1.17
0.86%
After-hours Jan 14, 2025, 03:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 4.73M | 3.69M | 3.29M | 778.00K | 303.25K | n/a |
| Gross Profit | -4.73M | -3.69M | -3.29M | -778.00K | -303.25K | n/a |
| Operating Income | -75.25M | -78.38M | -64.19M | -33.73M | -13.78M | -6.90M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -69.17M | -71.06M | -61.06M | -33.20M | -13.99M | -6.89M |
| Net Income | -69.67M | -71.18M | -61.10M | -33.20M | -13.99M | -6.89M |
| Selling & General & Admin | 12.34M | 21.12M | 21.97M | 11.10M | 4.70M | 2.10M |
| Research & Development | 67.65M | 57.26M | 42.22M | 22.63M | 9.07M | 4.80M |
| Other Expenses | -9.40M | 7.32M | 3.13M | 531.00K | -215.00K | n/a |
| Operating Expenses | 75.25M | 78.38M | 64.19M | 33.73M | 13.78M | 6.89M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | -4.67M | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 75.25M | 78.38M | 64.19M | 33.73M | 13.78M | 6.89M |
| Income Tax | 491.00K | 111.00K | 37.00K | 3.00K | 130.14K | n/a |
| Shares Outstanding (Basic) | 39.97M | 39.14M | 28.65M | 40.62M | 1.64M | 542.00K |
| Shares Outstanding (Diluted) | 39.97M | 39.14M | 28.65M | 40.62M | 1.64M | 542.59K |
| EPS (Basic) | -1.74 | -1.82 | -2.13 | -0.82 | -8.52 | -12.71 |
| EPS (Diluted) | -1.74 | -1.82 | -2.13 | -0.82 | -8.52 | -12.69 |
| EBITDA | -70.44M | -78.38M | -57.77M | -32.95M | -13.47M | -6.73M |
| Depreciation & Amortization | 4.73M | 3.69M | 3.29M | 778.00K | 303.25K | 173.00K |